AL-ABDALY PHARMA LTDActive
Key figures
Like most small UK companies, AL-ABDALY PHARMA LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025/26Balance sheet structure
Filed accounts2021/22–2025/26
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 7,175 | 26,791 | — | — | — |
| Total assets | 10,589 | 29,083 | 24,274 | 20,148 | 7,186 |
| Total liabilities | 10,916 | 10,840 | 4,823 | 3,706 | 4,103 |
| Net assets / total equity | 10 | 19,274 | 19,451 | 16,442 | 3,083 |
| Average number of employees | 1 | 0 | 1 | 1 | 1 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: AL-ABDALY PHARMA LTD
Company
AL-ABDALY PHARMA LTD is a private limited company registered with Companies House under company number 13445015. It was incorporated on 8 Jun 2021. Its status is active. The registered office is in Rochdale (OL11). Its nature of business (SIC 2007) is other human health activities (86900).
Accounts
The latest accounts in the database are for 2025/26 (period ending 30 Jun 2026); the company files micro-entity accounts. Net assets were £3,083, down 81.2% on the previous year. Total assets were £7,186 and total liabilities £4,103. The company had an average of 1 employee. Figures are available for 5 financial years (2021/22–2025/26).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Mar 2028. The next confirmation statement is due by 21 Jun 2027.